A New Mechanism of Lipotoxicity: Calcium Channel Blockers as a Treatment for Nonalcoholic Steatohepatitis?

Hepatology - United States
doi 10.1002/hep.27858
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)

Expert Opinion on Investigational Drugs
MedicinePharmacology
2019English

Dihydropyridines as Calcium Channel Blockers: An Overview

Journal of Analytical & Pharmaceutical Research
2017English

The Mechanism of Action of Calcium Channel Blockers in the Treatment of Diabetic Nephropathy

International Journal of Diabetes and Metabolism
2005English

T-Type Calcium Channel Blockers as Neuroprotective Agents

Pflugers Archiv European Journal of Physiology
Clinical BiochemistryPhysiology
2014English

Natural Products: New Hope for Nonalcoholic Steatohepatitis?

Journal of Medicinal Food
MedicineNutritionDietetics
2019English

Calcium Channel Blockers and Dementia

British Journal of Pharmacology
Pharmacology
2013English

New Therapeutic Strategies in Nonalcoholic Fatty Liver Disease: A Focus on Promising Drugs for Nonalcoholic Steatohepatitis

Pharmacological Reports
MedicinePharmacology
2020English

Treatment of Poisoning Caused by -Adrenergic and Calcium-Channel Blockers

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2006English

Calcium-Channel Blockers and Anaesthesia

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy